Protein Function

Scientists Identify TRNAU1AP Pathway That Sustains Glioblastoma Stem Cells

Disrupting IGF2BP3's stabilization of TRNAU1AP could weaken selenoprotein defenses that help therapy‑resistant tumor stem cells.